Tango Therapeutics IPO

tangotx.com

Tango Therapeutics delivers the next generation of precision medicine to people with cancer that leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at driver genes in cancer.

Founded2014
Total Funding to Date$166.88MM
Register for Details

For more details on financing and valuation for Tango Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Tango Therapeutics Ticker Symbol

Tango Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Tango Therapeutics Stock Price

The stock price for Tango Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Tango Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
8/17/2020 Series B-1 $305.79MM $XXX.XX $XXX.XX
4/9/2020 Series B $170MM $XXX.XX $XXX.XX
3/30/2017 Series A $70.89MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Tango Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B